Giulia De Riso
Overview
Explore the profile of Giulia De Riso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Riso G, Naef V, Damiani D, Doccini S, Santorelli F, Galatolo D
Cerebellum
. 2025 Jan;
24(2):36.
PMID: 39853590
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a rare inherited condition described worldwide and characterized by a wide spectrum of heterogeneity in terms of genotype and phenotype. How sacsin...
2.
Bonfiglio F, Legati A, Lasorsa V, Palombo F, De Riso G, Isidori F, et al.
Hum Genomics
. 2024 Nov;
18(1):120.
PMID: 39501379
This comprehensive review provides insights and suggested strategies for the analysis of germline variants using second- and third-generation sequencing technologies (SGS and TGS). It addresses the critical stages of data...
3.
Maritato R, Medugno A, DAndretta E, De Riso G, Lupo M, Botta S, et al.
Sci Rep
. 2024 Nov;
14(1):26313.
PMID: 39487168
Gene expression emerges from DNA sequences through the interaction of transcription factors (TFs) with DNA cis-regulatory sequences. In eukaryotes, TFs bind to transcription factor binding sites (TFBSs) with differential affinities,...
4.
Cuomo M, Coretti L, Costabile D, Della Monica R, De Riso G, Buonaiuto M, et al.
Sci Rep
. 2023 Oct;
13(1):18197.
PMID: 37875530
The gut-brain axis involves several bidirectional pathway communications including microbiome, bacterial metabolites, neurotransmitters as well as immune system and is perturbed both in brain and in gastrointestinal disorders. Consistently, microbiota-gut-brain...
5.
Della Monica R, Buonaiuto M, Cuomo M, Pagano C, Trio F, Costabile D, et al.
Cell Death Dis
. 2023 Sep;
14(9):638.
PMID: 37758718
Despite intense research efforts, glioblastoma remains an incurable brain tumor with a dismal median survival time of 15 months. Thus, identifying new therapeutic targets is an urgent need. Here, we...
6.
De Riso G, Sarnataro A, Scala G, Cuomo M, Della Monica R, Amente S, et al.
NAR Genom Bioinform
. 2023 Jan;
4(4):lqac096.
PMID: 36601577
DNA methylation is an epigenetic mark implicated in crucial biological processes. Most of the knowledge about DNA methylation is based on bulk experiments, in which DNA methylation of genomic regions...
7.
Sarnataro A, De Riso G, Cocozza S, Pezone A, Majello B, Amente S, et al.
Comput Struct Biotechnol J
. 2022 Nov;
20:5925-5934.
PMID: 36382198
DNA methylation is an epigenetic modification that plays a pivotal role in major biological mechanisms, such as gene regulation, genomic imprinting, and genome stability. Different combinations of methylated cytosines for...
8.
Cuomo M, Florio E, Della Monica R, Costabile D, Buonaiuto M, Di Risi T, et al.
Sci Rep
. 2022 Apr;
12(1):6471.
PMID: 35440736
FXYD1 is a key protein controlling ion channel transport. FXYD1 exerts its function by regulating Na/K-ATPase activity, mainly in brain and cardiac tissues. Alterations of the expression level of the...
9.
Roca M, Moccia T, Iannelli F, Testa C, Vitagliano C, Minopoli M, et al.
J Exp Clin Cancer Res
. 2022 Apr;
41(1):138.
PMID: 35410264
No abstract available.
10.
Roca M, Moccia T, Iannelli F, Testa C, Vitagliano C, Minopoli M, et al.
J Exp Clin Cancer Res
. 2022 Mar;
41(1):83.
PMID: 35241126
Background: Pancreatic ductal adenocarcinoma (PDAC) represents an unmet clinical need due to the very poor prognosis and the lack of effective therapy. Here we investigated the potential of domatinostat (4SC-202),...